Angion Biomedica Corp.
ANGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | -$0 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | -91.9% | – |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | – | – | 100% | 98.5% |
| EBITDA | -$0 | – | -$0 | -$0 |
| % Margin | – | – | -874.3% | -196.5% |
| Net Income | -$0 | – | -$0 | -$0 |
| % Margin | – | – | -2,420.7% | -189.9% |
| EPS Diluted | -4.25 | – | -1.85 | -1.9 |
| % Growth | – | – | 2.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |